Latest Period
Q2 2026
Security Snapshot
Outset Medical, Inc. - Common Stock (OM) Institutional Ownership
CUSIP: 690145206
13F Institutional Holders and Ownership History from Q1 2025 to Q2 2026
Institutions Reporting
92
Shares (Excl. Options)
13,847,261
Price
$4.32
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock
- Symbol
- OM on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 13,847,261
- Total 13F value
- $59,820,040
- Portfolio coverage rank
- 0%
- Share change
- -904,550
- Value change
- -$3,604,278
- Number of holders
- 92
- Shares outstanding
- 19,045,600
- SEC-reported price per share
- $4.99
- Insider filing price
- $4.99
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- OM - Outset Medical, Inc. - Common Stock is tracked under CUSIP 690145206.
- 92 institutions reported positions in Q2 2026.
- 9 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 94 to 92 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $56,664,510 to $59,820,040.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 92 institutions filings for Q2 2026.
Security key
690145206
Latest holder period
Q2 2026
13F holders
92
13D/G owners
9
CIK / CUSIP context first
Open Q2 2026 holders
OM full holder history
Outset Medical, Inc. SEC filings
Outset Medical, Inc. company facts
Outset Medical, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 690145206:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
9
Security
OM
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| FMR LLC | 14% | $30,149,556 | 2,596,861 | FMR LLC | 31 Mar 2025 | |||
| BML Investment Partners, L.P. | 10% | +12% | $9,739,269 | +$1,005,184 | 1,902,201 | +12% | BML Investment Partners, L.P. | 12 Feb 2026 |
| Woodline Partners LP | 7.5% | $15,392,352 | 1,325,784 | Woodline Partners LP | 31 Mar 2025 | |||
| PERCEPTIVE ADVISORS LLC | 6.7% | $14,028,758 | 1,208,334 | Perceptive Advisors LLC | 31 Mar 2025 | |||
| AQR CAPITAL MANAGEMENT LLC | 5.4% | $4,445,376 | 998,961 | AQR Capital Management, LLC | 30 Jun 2026 | |||
| VANGUARD GROUP INC | 5.6% | $18,919,737 | 991,429 | The Vanguard Group | 30 Jun 2025 | |||
| BANK OF AMERICA CORP /DE/ | 3.5% | -34% | $2,966,352 | -$1,263,631 | 666,596 | -30% | BANK OF AMERICA CORP /DE/ | 30 Jun 2026 |
| BlackRock, Inc. | 2% | -69% | $1,579,531 | -$3,664,084 | 365,556 | -70% | BlackRock, Inc. | 30 Jun 2026 |
| T. Rowe Price Investment Management, Inc. | 0% | -99% | $33,874 | -$22,601,277 | 2,399 | -100% | T. Rowe Price Investment Management, Inc. | 30 Sep 2025 |
As of 30 Jun 2026, 92 institutional investors reported holding 13,847,261 shares of Outset Medical, Inc. - Common Stock (OM). This represents 73% of the company’s total 19,045,600 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
67%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| FMR LLC | 14% | 2,742,887 | +0.04% | 0% | $11,849,272 |
| BML Capital Management, LLC | 13% | 2,519,701 | +32% | 6.2% | $10,885,108 |
| AQR CAPITAL MANAGEMENT LLC | 5.2% | 998,961 | +24% | 0% | $4,315,512 |
| PERCEPTIVE ADVISORS LLC | 4.4% | 833,333 | 0% | 0.06% | $3,599,998 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.1% | 780,134 | +2.1% | 0% | $3,370,179 |
| BANK OF AMERICA CORP /DE/ | 3.5% | 665,847 | -30% | 0% | $2,876,459 |
| PFM Health Sciences, LP | 3.1% | 582,122 | -2.1% | 0.22% | $2,514,767 |
| Ensign Peak Advisors, Inc | 2.3% | 434,341 | -18% | 0% | $1,876,353 |
| BlackRock, Inc. | 2.2% | 418,211 | -67% | 0% | $1,806,671 |
| Assenagon Asset Management S.A. | 1.8% | 339,438 | -33% | 0% | $1,466,372 |
| Peapod Lane Capital LLC | 1.7% | 331,951 | 0.97% | $1,434,028 | |
| MARSHALL WACE, LLP | 1.1% | 211,993 | 0% | $915,809 | |
| GEODE CAPITAL MANAGEMENT, LLC | 1.1% | 204,652 | -51% | 0% | $884,538 |
| Stratos Wealth Partners, LTD. | 1.1% | 200,546 | 0% | 0.01% | $866,359 |
| UBS Group AG | 1% | 190,289 | -25% | 0% | $822,048 |
| MORGAN STANLEY | 0.96% | 181,983 | +7.4% | 0% | $786,166 |
| MILLENNIUM MANAGEMENT LLC | 0.95% | 181,794 | 0% | $785,350 | |
| GOLDMAN SACHS GROUP INC | 0.91% | 173,460 | +86% | 0% | $749,348 |
| JANE STREET GROUP, LLC | 0.73% | 139,197 | +115% | 0% | $601,331 |
| XTX Topco Ltd | 0.65% | 124,690 | -12% | 0.01% | $538,661 |
| Catalio Capital Management, LP | 0.62% | 118,279 | 0% | 0.1% | $510,965 |
| VANGUARD FIDUCIARY TRUST CO | 0.6% | 114,912 | +2.9% | 0% | $496,420 |
| GMT Capital Corp | 0.52% | 98,108 | +131% | 0.02% | $423,827 |
| DIMENSIONAL FUND ADVISORS LP | 0.48% | 90,698 | -20% | 0% | $391,828 |
| PURA VIDA INVESTMENTS, LLC | 0.44% | 83,333 | 0% | 0.97% | $359,999 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
6
Latest
Q2 2026
Rows shown
1-6 of 6
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 13,847,261 | $59,820,040 | -$3,604,278 | $4.32 | 92 |
| 2026 Q1 | 14,763,608 | $56,664,510 | -$2,416,607 | $3.84 | 94 |
| 2025 Q4 | 15,349,620 | $56,944,212 | -$38,452,367 | $3.71 | 94 |
| 2025 Q3 | 17,649,176 | $249,202,204 | -$11,456,191 | $14.12 | 96 |
| 2025 Q2 | 18,242,288 | $350,434,222 | +$69,197,262 | $19.21 | 91 |
| 2025 Q1 | 14,676,599 | $162,319,841 | +$162,319,498 | $11.06 | 59 |